|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Amundadottir L, Kraft P,
Stolzenberg-Solomon RZ, Fuchs CS, Petersen GM, Arslan AA,
Bueno-de-Mesquita HB, Gross M, Helzlsouer K, Jacobs EJ, et al:
Genome-wide association study identifies variants in the ABO locus
associated with susceptibility to pancreatic cancer. Nat Genet.
41:986–990. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hidalgo M: Pancreatic cancer. N Engl J
Med. 362:1605–1617. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Martens-Uzunova ES, Bottcher R, Croce CM,
Jenster G, Visakorpi T and Calin GA: Long noncoding RNA in
prostate, bladder, and kidney cancer. Eur Urol. 65:1140–1151. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huang G, Wu X, Li S, Xu X, Zhu H and Chen
X: The long noncoding RNA CASC2 functions as a competing endogenous
RNA by sponging miR-18a in colorectal cancer. Sci Rep. 6:265242016.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fan JC, Zeng F, Le YG and Xin L: LncRNA
CASC2 inhibited the viability and induced the apoptosis of
hepatocellular carcinoma cells through regulating miR-24-3p. J Cell
Biochem. 119:6391–6397. 2018. View Article : Google Scholar
|
|
9
|
Wang Y, Liu Z, Yao B, Li Q, Wang L, Wang
C, Dou C, Xu M, Liu Q and Tu K: Long non-coding RNA CASC2
suppresses epithelial-mesenchymal transition of hepatocellular
carcinoma cells through CASC2/miR-367/FBXW7 axis. Mol Cancer.
16:1232017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ba Z, Gu L, Hao S, Wang X, Cheng Z and Nie
G: Downregulation of lncRNA CASC2 facilitates osteosarcoma growth
and invasion through miR-181a. Cell Prolif. 51:pp. e124092018,
View Article : Google Scholar
|
|
11
|
Yu Y, Liang S, Zhou Y, Li S, Li Y and Liao
W: HNF1A/CASC2 regulates pancreatic cancer cell proliferation
through PTEN/Akt signaling. J Cell Biochem. 120:2816–2827. 2019.
View Article : Google Scholar
|
|
12
|
Liu R, Chen X, Du Y, Yao W, Shen L, Wang
C, Hu Z, Zhuang R, Ning G, Zhang C, et al: Serum microRNA
expression profile as a biomarker in the diagnosis and prognosis of
pancreatic cancer. Clin Chem. 58:610–618. 2012. View Article : Google Scholar
|
|
13
|
Volinia S, Calin GA, Liu CG, Ambs S,
Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, et
al: A microRNA expression signature of human solid tumors defines
cancer gene targets. Proc Natl Acad Sci USA. 103:2257–2261. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jin X, Cai L, Wang C, Deng X, Yi S, Lei Z,
Xiao Q, Xu H, Luo H and Sun J: CASC2/miR-24/miR-221 modulates the
TRAIL resistance of hepatocellular carcinoma cell through
caspase-8/caspase-3. Cell Death Dis. 9:3182018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ringel J and Löhr M: The MUC gene family:
Their role in diagnosis and early detection of pancreatic cancer.
Mol Cancer. 2:92003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Suh H, Pillai K and Morris DL: Mucins in
pancreatic cancer: Biological role, implications in carcinogenesis
and applications in diagnosis and therapy. Am J Cancer Res.
7:1372–1383. 2017.PubMed/NCBI
|
|
17
|
Sierzega M, Mlynarski D, Tomaszewska R and
Kulig J: Semiquantitative immunohistochemistry for mucin (MUC1,
MUC2, MUC3, MUC4, MUC5AC, and MUC6) profiling of pancreatic ductal
cell adenocarcinoma improves diagnostic and prognostic performance.
Histopathology. 69:582–591. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jonckheere N, Skrypek N and Van Seuningen
I: Mucins and pancreatic cancer. Cancers (Basel). 2:1794–1812.
2010. View Article : Google Scholar
|
|
19
|
Leir SH and Harris A: MUC6 mucin
expression inhibits tumor cell invasion. Exp Cell Res.
317:2408–2419. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Baril P, Gangeswaran R, Mahon PC, Caulee
K, Kocher HM, Harada T, Zhu M, Kalthoff H, Crnogorac-Jurcevic T and
Lemoine NR: Periostin promotes invasiveness and resistance of
pancreatic cancer cells to hypoxia-induced cell death: Role of the
beta4 integrin and the PI3k pathway. Oncogene. 26:2082–2094. 2007.
View Article : Google Scholar
|
|
21
|
Lakshmanan I, Rachagani S, Hauke R, Krishn
SR, Paknikar S, Seshacharyulu P, Karmakar S, Nimmakayala RK,
Kaushik G, Johansson SL, et al: MUC5AC interactions with integrin
β4 enhances the migration of lung cancer cells through FAK
signaling. Oncogene. 35:4112–4121. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zou M, Huang W, Jiang W, Wu Y and Chen Q:
Role of Cav-1 in HIV-1 Tat-induced dysfunction of tight junctions
and Aβ-transferring proteins. Oxid Med Cell Longev.
2019:34032062019. View Article : Google Scholar
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
24
|
Sieg DJ, Hauck CR, Ilic D, Klingbeil CK,
Schaefer E, Damsky CH and Schlaepfer DD: FAK integrates
growth-factor and integrin signals to promote cell migration. Nat
Cell Biol. 2:249–256. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yano H, Mazaki Y, Kurokawa K, Hanks SK,
Matsuda M and Sabe H: Roles played by a subset of integrin
signaling molecules in cadherin-based cell-cell adhesion. J Cell
Biol. 166:283–295. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu P, Yang H, Zhang J, Peng X, Lu Z, Tong
W and Chen J: The lncRNA MALAT1 acts as a competing endogenous RNA
to regulate KRAS expression by sponging miR-217 in pancreatic
ductal adenocarcinoma. Sci Rep. 7:51862017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Deng SJ, Chen HY, Ye Z, Deng SC, Zhu S,
Zeng Z, He C, Liu ML, Huang K, Zhong JX, et al: Hypoxia-induced
LncRNA-BX111 promotes metastasis and progression of pancreatic
cancer through regulating ZEB1 transcription. Oncogene.
37:5811–5828. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Giulietti M, Righetti A, Principato G and
Piva F: LncRNA co-expression network analysis reveals novel
biomarkers for pancreatic cancer. Carcinogenesis. 39:1016–1025.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tay Y, Rinn J and Pandolfi PP: The
multilayered complexity of ceRNA crosstalk and competition. Nature.
505:344–352. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kerimis D, Kontos CK, Christodoulou S,
Papadopoulos IN and Scorilas A: Elevated expression of miR-24-3p is
a potentially adverse prognostic factor in colorectal
adenocarcinoma. Clin Biochem. 50:285–292. 2017. View Article : Google Scholar
|
|
32
|
Listing H, Mardin WA, Wohlfromm S, Mees ST
and Haier J: miR-23a/-24-induced gene silencing results in
mesothelial cell integration of pancreatic cancer. Br J Cancer.
112:131–139. 2015. View Article : Google Scholar :
|
|
33
|
Jing P, Zhao N, Xie N, Ye M, Zhang Y,
Zhang Z, Li M, Lai X, Zhang J and Gu Z: miR-24-3p/FGFR3 signaling
as a novel axis is involved in epithelial-mesenchymal transition
and regulates lung adenocarcinoma progression. J Immunol Res.
2018:28341092018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mohr AM, Bailey JM, Lewallen ME, Liu X,
Radhakrishnan P, Yu F, Tapprich W and Hollingsworth MA: MUC1
regulates expression of multiple microRNAs involved in pancreatic
tumor progression, including the miR-200c/141 cluster. PLoS One.
8:e733062013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lahdaoui F, Delpu Y, Vincent A, Renaud F,
Messager M, Duchêne B, Leteurtre E, Mariette C, Torrisani J,
Jonckheere N and Van Seuningen I: miR-219-1-3p is a negative
regulator of the mucin MUC4 expression and is a tumor suppressor in
pancreatic cancer. Oncogene. 34:780–788. 2015. View Article : Google Scholar
|
|
36
|
Kim GE, Bae HI, Park HU, Kuan SF, Crawley
SC, Ho JJ and Kim YS: Aberrant expression of MUC5AC and MUC6
gastric mucins and sialyl Tn antigen in intraepithelial neoplasms
of the pancreas. Gastroenterology. 123:1052–1060. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yu L, Chen S, Bao H, Zhang W, Liao M,
Liang Q and Cheng X: The role of lncRNA CASC2 on prognosis of
malignant tumors: A meta-analysis and bioinformatics. Onco Targets
Ther. 11:4355–4365. 2018. View Article : Google Scholar : PubMed/NCBI
|
